Inducible STAT3 NH2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis

Sutapa Ray1, Yingxin Zhao2, Mohammad Jamaluddin3

  • 1Sealy Center for Molecular Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, United States.

Cellular Signalling
|March 25, 2014
PubMed

Insights

Signal Transducers and Activator of Transcription-3 (STAT3) mono-ubiquitination enhances its interaction with BRD4, promoting anti-apoptotic and pro-proliferative gene expression. This pathway represents a potential therapeutic target for STAT3-dependent diseases.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Signal Transducers and Activator of Transcription-3 (STAT3) are key transcription factors regulated by post-translational modifications (PTMs).
  • STAT3 activation by the IL-6 cytokine superfamily controls cell cycle progression and apoptosis.
  • The specific role of STAT3 mono-ubiquitination in these processes remains largely uncharacterized.

Purpose of the Study:

  • To investigate the consequences of STAT3 mono-ubiquitination.
  • To identify the specific site of STAT3 mono-ubiquitination.
  • To elucidate the functional implications of STAT3 mono-ubiquitination in gene regulation and cellular processes.

Main Methods:

  • Domain mapping and selected reaction monitoring-mass spectrometry to identify ubiquitination sites.
  • Construction of a deubiquitinase-resistant ubiquitinated-STAT3 mimic (ubiquitinated-STAT3 FP).
  • Co-immunoprecipitation assays, chromatin immunoprecipitation, and gene expression analysis (qPCR, Western blotting).

Main Results:

  • Lysine 97 (K97) in the NH2-terminal domain was identified as the primary mono-ubiquitination site on STAT3.
  • Ubiquitinated-STAT3 FP showed enhanced complex formation with bromodomain-containing protein 4 (BRD4).
  • STAT3 mono-ubiquitination promoted BRD4 recruitment to the SOCS3 gene promoter, enhancing STAT3-dependent transcription.
  • Expression of ubiquitinated-STAT3 FP upregulated anti-apoptotic (BCL2, BCL2L1, APEX1, SOD2) and pro-proliferative (CCND1, MYC) genes.
  • Ubiquitinated-STAT3 FP suppressed TNFα-induced apoptosis.

Conclusions:

  • STAT3 mono-ubiquitination at K97 is a critical regulatory event.
  • Mono-ubiquitinated STAT3 enhances BRD4-dependent transcription, driving anti-apoptotic and pro-proliferative gene expression programs.
  • The STAT3 mono-ubiquitination-BRD4 pathway is a potential therapeutic target for STAT3-dependent proliferative diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K